COLLEGIUM PHARMACEUTICAL, INC : Submission of Matters to a Vote of Security Holders (form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

A total of 34,581,020 shares of common stock of Collegium Pharmaceutical, Inc. (the "Company")were entitled to vote as of March 31, 2023, the record date for the Annual Meeting, of which 30,815,695 were present in person or by proxy at the Annual Meeting. The following is a summary of the final voting results for each matter presented to shareholders.

PROPOSAL 1:



Election of nine Directors to hold office until the 2024 Annual Meeting of
Shareholders.



Nominee                  For            Against        Abstentions       Broker Non-Votes
Rita Balice-Gordon     28,110,968        228,126           20,717             2,455,884
Garen Bohlin           28,254,994        83,040            21,777             2,455,884
Joseph Ciaffoni        28,252,708        86,385            20,718             2,455,884
John Fallon            25,876,429       2,462,321          21,061             2,455,884
John Freund            28,244,410        94,340            21,061             2,455,884
Michael Heffernan      26,667,450       1,671,643          20,718             2,455,884
Neil McFarlane         28,255,598        83,495            20,718             2,455,884
Gwen Melincoff         27,982,535        353,536           23,740             2,455,884
Gino Santini           28,128,667        210,074           21,070             2,455,884

Each of Rita Balice-Gordon, Garen Bohlin, Joseph Ciaffoni, John Fallon, John Freund, Michael Heffernan, Neil F. McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2024 Annual Meeting of Shareholders.

PROPOSAL 2:



Approval of, on an advisory basis, the compensation of the Company's named
executive officers.



    For           Against       Abstentions       Broker Non-Votes
  27,953,926       315,383          90,502             2,455,884

On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.

PROPOSAL 3:

Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.

    For          Against       Abstentions      Broker Non-Votes
  30,742,534       44,006          29,155                   0

Proposal 3 was approved by the Company's shareholders.

© Edgar Online, source Glimpses